← Back to Search

CBT for Social Anxiety Disorder

N/A
Waitlist Available
Led By Heide Klumpp, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 0, 6, and 12
Awards & highlights

Study Summary

This trial will compare cognitive behavioral therapy to a placebo psychotherapy in patients with Major Depressive Disorder and generalized Social Anxiety Disorder to test how effective CBT is and for whom.

Eligible Conditions
  • Depression
  • Social Anxiety Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 0, 6, and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 0, 6, and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
BOLD Effects Measured with Functional Magnetic Resonance Imaging (fMRI)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: CBTActive Control1 Intervention
The clinical psychologist will use a manualized CBT approach tailored to MDD or gSAD. Over a 12-week period sessions will include core CBT strategies -- psychoeducation, cognitive intervention (e.g., cognitive restructuring), behavioral changes (i.e., fear exposure, behavioral activation strategies) and relapse prevention.
Group II: STPlacebo Group1 Intervention
The clinical psychologist will use an ST approach that resembles client-centered therapy of Carl Rogers (1951) which has been used as a control psychotherapy. The manual is based on supportive psychotherapy principles. Over a 12-week period sessions will emphasize reflective listening and elicitation of affect. In contrast to CBT, therapists allow patients to determine the focus of each session, pulling for emotion, validating emotions when possible, and offering empathetic comments. Therapists will refrain from delineating any CBT theoretical framework and avoided cognitive and behavioral techniques that might overlap with CBT.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
608 Previous Clinical Trials
1,559,046 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,785 Previous Clinical Trials
2,689,553 Total Patients Enrolled
Heide Klumpp, PhDPrincipal Investigator - University of Illinois at Chicago
University of Illinois at Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response
Heide Klumpp 2017. "Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03175068.
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top